Controlled Release of Recombinant Human Nerve Growth Factor (rhngf) from Poly[(lactic Acid)‐co‐(glycolic Acid)] Microspheres for the Treatment of Neurodegenerative Disorders

Haigang Gu,Cunxian Song,Dahong Long,Lin Mei,Hongfan Sun
DOI: https://doi.org/10.1002/pi.2272
IF: 3.213
2007-01-01
Polymer International
Abstract:Recombinant human nerve growth factor (rhNGF)/bovine serum albumin-loaded microspheres were prepared by a water/oil/water emulsion and solvent evaporation technique with some modifications. The microspheres were characterized with respect to encapsulation efficiency, morphological properties and drug release. Using higher protein/polymer ratios in the primary emulsion resulted in higher protein content in the microspheres. The protein encapsulation efficiency increased from 89.1% to 97.5% on adding poly(ethylene glycol) to the inner aqueous phase. The in vitro rhNGF release lasted for more than 5 weeks. The biological activity of released rhNGF was confirmed by PC12 cell culture. The microspheres maintained a sustained release of rhNGF for at least 4weeks in the basal forebrain as detected by fluorescence-labeled and indirect immunofluorescent techniques. These results demonstrated the rhNGF-containing microspheres are an effective means for delivering this molecule into the brain and their use may be a promising strategy in the treatment of neurodegenerative disorders such as Alzheimer's disease. (c) 2007 Society of Chemical Industry.
What problem does this paper attempt to address?